Register for email alerts and news feeds:
This journal | BMJ Group
rss
Postgraduate Medical Journal 2007;83:e1; doi:10.1136/pgmj.2006.055194
© 2007 BMJ Publishing Group Ltd and The Fellowship of Postgraduate Medicine.

ADVERSE DRUG REACTION

Sulfasalazine-induced immune thrombocytopenia

L Cantarini1, I Tinazzi2, D Biasi2, A Fioravanti1, M Galeazzi1

1 Rheumatology Unit, Department of Clinical Medicine and Immunological Sciences, University of Siena, Italy
2 Department of Clinical and Experimental Medicine, University of Verona, Italy

Correspondence to:
Correspondence to:
Dr Ilaria Tinazzi
Department of Clinical and Experimental Medicine, University of Verona, Pz.le Scuro,10 37134; Verona, Italy; ilariatinazzi{at}yahoo.it

Sulfasalazine is a well established disease-modifying anti-rheumatic drug commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. Sulfasalazine was generally well tolerated in clinical trials, the most frequently reported adverse effects being adverse gastrointestinal effects, headache, dizziness and rash; myelosuppression can also occur. We are now reporting the first case of autoimmune thrombocytosis following sulfasalazine treatment.

Abbreviations: NSAIDs, non-steroidal, anti-inflammatory drugs; SLE, systemic lupus erythematosus; TNF{alpha}, tumour necrosis factor {alpha}


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.